| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Chrysin | Asthma | 2 | PM | 26780233 | 📋 | Chrysin Alleviates Allergic Inflammation and Airway Remodeling in a Murine Model of Chronic Asthma |
| Chrysin | Asthma | 1 | PM | 26710703 | 📋 | [Effects of Chrysin on Steroid-Resistant Asthma in a Murine Model] |
| Chrysin | Asthma | 3 | PM | 26502995 | 📋 | Chrysin Inhibits Human Airway Smooth Muscle Cells Proliferation Through the Extracellular Signal-Regulated Kinase 1/2 Signaling Pathway |
| Chrysin | Atopic Dermatitis | 3 | PM | 33919431 | 📋 | Chrysin Inhibits TNFα-Induced TSLP Expression through Downregulation of EGR1 Expression in Keratinocytes |
| Chrysin | Atopic Dermatitis | 2 | PM | 33027922 | 📋 | Chrysin Inhibits NF-κB-Dependent CCL5 Transcription by Targeting IκB Kinase in the Atopic Dermatitis-Like Inflammatory Microenvironment |
| Chrysin | Atopic Dermatitis | 1 | PM | 29050978 | 📋 | Chrysin Attenuates Atopic Dermatitis by Suppressing Inflammation of Keratinocytes |
| Chrysin | Chronic Inflammation | 1 | PM | 33027922 | 📋 | Chrysin Inhibits NF-κB-Dependent CCL5 Transcription by Targeting IκB Kinase in the Atopic Dermatitis-Like Inflammatory Microenvironment |
| Chrysin | Diabetes Type 1 | 1 | PM | 35058687 | 📋 | Chrysin Attenuates High Glucose-Induced BMSC Dysfunction via the Activation of the PI3K/AKT/Nrf2 Signaling Pathway |
| Chrysin | Multiple Sclerosis | 2 | PM | 31376787 | 📋 | Chrysin Suppress Immune Responses and Protects From Experimental Autoimmune Encephalomyelitis in Mice |
| Chrysin | Multiple Sclerosis | 3 | PM | 28671640 | 📋 | Chrysin Attenuates VCAM-1 Expression and Monocyte Adhesion in Lipopolysaccharide-Stimulated Brain Endothelial Cells by Preventing NF-κB Signaling |
| Chrysin | Multiple Sclerosis | 1 | PM | 26531689 | 📋 | Chrysin Suppresses Human CD14(+) Monocyte-Derived Dendritic Cells and Ameliorates Experimental Autoimmune Encephalomyelitis |
| Chrysin | Psoriasis | 1 | PM | 32076123 | 📋 | Chrysin Alleviates Imiquimod-Induced Psoriasis-Like Skin Inflammation and Reduces the Release of CCL20 and Antimicrobial Peptides |
